CDK4+Cyclin D1 NanoBRET Target Engagement Intracellular Kinase Assay for screening of compounds binding to the target.
Target Overview
Target
CDK4+Cyclin D1
HGNC Symbol
CDK4/CCND1 complex
Synonyms
CMM3; PSK-J3; MGC14458
Cell Line
HEK293 human epithelial cell line from ATCC
Assay Properties
Assay Format
384-well plate format using Promega’s NanoBRET TE Intracellular Kinase Assay
Assay Protocol
HEK293 cells transiently co-expressing NanoLuc-CDK4 fusion vector and Cyclin D1 Vector were seeded into the wells of 384-well plates. The cells were pretreated with the NanoBRET Tracer K-7 and then treated with reference compound Palbociclib for 1 hour. The BRET signal was measured on an Envision 2104 Multilabel Reader. IC50 value was calculated and IC50 curve was plotted using the GraphPad Prism 4 program based on a sigmoidal dose response equation.
Readout
Binding of compound to target kinase
Reference Compound IC50s
| Compounds | IC50 (M) |
|---|---|
| Palbociclib | 4.028e-009 |
Screening Location
Malvern, USA
PDF